Treatment with FoxM1-shRNA or IR alone moderately reduced tumor burden and weight in mice bearing Eca-109 subcutaneous tumors compared with the NC group (FoxM1-shRNA: T/C%= 51.1%; NC+IR: T/C%=41.1%) (Figure 5A,B). The gene discussed is FOXM1; the disease is neoplasm.